The antimicrobial activity of twenty two synthetic fl avonoids is reported. Among them three 3-arylidenefl avanones, 2b, 2c, and 2i, were shown to be highly active against Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis reference strains, with MIC (minimal inhibitory concentration) values ranging from 4.68 μg/ml (14.3 μM) to 37.5 μg/ml (119.7 μM). The synergy of oxacillin and vancomycin with 2c, evaluated as fractional inhibitory concentration index (FICI) was shown (against planktonic culture of S. aureus A3 and E. faecium 138/09 clinical strains). The presence of 2c in the culture medium diminished the initial adhesion of bacteria to an abiotic surface. Such an effect resulted in a decrease in biofi lm formation during prolonged culture. Unfortunately, 2c failed to eradicate the S. aureus mature biofi lm which was already preformed, however, decreased the number of live biofi lm cells. The biofi lm of E. faecalis was more susceptible to the action of 3-arylidenefl avanone 2c than the S. aureus biofi lm. The fi nding that 3-arylidenefl avanones are lipophilic, cause bacterial aggregation, and infl uence the integrity of membranes making them permeable to SYTO 9/propidium iodide dyes may implicate the cytoplasmic membrane as a target site for these compounds activity.
Introduction
Bacterial and fungal pathogens have developed numerous resistance mechanisms against antimicrobial agents. Moreover, microorganisms tend to form biofi lm communities which are very diffi cult to control because of their extremely high resistance to antibiotics and the host defense system. It therefore seems to be necessary to search for alternative strategies to combat infections of biofi lm nature and the best solution being the prevention of their adhesion (Rice, 2006) . Currently, natural plant compounds are in the focus of attention as a source or, which is no less interesting, as molecular patterns for new drugs (Dürig et al., 2010) . Usually, their structures differ from those of microbes-derived antibiotics and also their action proceeds via different mechanisms. These dissimilarities greatly increase the chance of avoiding rapid development of microbial resistance. One of the large interesting groups of phytochemicals is the class of fl avonoids which are ubiquitously present and perform a protective function in abiotic and biotic stress (Gibbons, 2008) . They have been shown to display a wide range of medicinal properties including antibacterial, antifungal, anti-infl ammatory, and anticancer effects, respectively (Cushnie and Lamb, 2005; Deng et al., 2000; Sato et al., 1994; Konieczny et al., 2007; Chikhalia et al., 2008) . Some of these phytochemicals, due to their simple structure and potentially facile de novo synthesis, are worth further investigation (Prasad et al., 2008; Mughal et al., 2006; Andersen and Markham, 2006) .
Based on the published data showing that chromone derivatives like chalcones and fl avanones show antimicrobial activity (Gatto et al., 2002; Lahtchev et al., 2008; Avila et al., 2008) , the aim of our study was to search among the compounds synthesized and owned by us for compounds with such potency. We focused our attention on the possibility to fi ght the two main members of the "alert" pathogens group, i.e. the staphylococci Staphylococcus aureus and S. epidermidis (methicillin-resistant, MRSA, MRSE) and enterococci (including the vancomycin-resistant Enterococcus faecium, VRE). These pathogens were chosen as targets because of the availability of epidemiological data on the incidence of infections they cause or contribute to (Rice, 2006) . S. aureus and S. epidermidis are common types of bacteria but one major problem is that occasionally a mild skin infection can spread to almost any other organ in the body and become life-threatening. Moreover, the resistance of staphylococci to methicillin means that they are resistant to all β-lactam antibiotics as well, which implies the need to search for new therapeutics. Enterococci can often cause harmless infections of the urinary tract and wounds. If such infections are caused by strains resistant to vancomycin and/or affect the bloodstream, they are very diffi cult to treat (Rice, 2006; Goetz, 2002; Fux et al., 2005; Mohamed and Huang, 2007) . Thus, in the fi rst part of this work, synthetic 2'-hydroxychalcones, 3-arylidenefl avanones, and 3-arylidenechromanones were screened for their bacteriostatic/bactericidal effect against reference and clinical Staphylococcus and Enterococcus strains. The susceptibility of S. aureus and E. faecium multidrug-resistant strains, to oxacillin or vancomycin alone or in combination with selected compounds, was also tested. Then, compounds showing the highest activity were tested for their anti-adhesion and anti-biofi lm potency. For comparison, the effects of reference antibiotics and phytochemicals were determined.
Material and Methods

Synthesis and chemical characteristics of fl avonoids
The 2'-hydroxychalcones 1a -1j were prepared according to the procedure given in the literature (Prasad et al., 2008) . The 3-arylidenefl avanones 2a -2i were obtained by a three-step synthesis. In the fi rst step, chalcones were synthesized by the Claisen-Schmidt reaction (Raval and Shah, 1956 ). The substituted fl avanones were obtained from precedent chalcones according to the procedure reported in the literature (Geissman and Clinton, 1946 ). The fl avanones were then condensed with dedicated aldehydes in the presence of piperidine as a catalyst (Pijewska et al., 1993) . The 3-arylidenechromanones 3a -3c were also synthesized by the above-mentioned condensation method using commercially available chromanone and appropriate aldehydes.
The compounds were fi nally purifi ed by repeated crystallization from ethanol. The chemical 2a, 2c, 2d, 2h , and 3a were confi rmed on the basis of the spectral analysis data presented in a previous publication (Pijewska et al., 1993) .
Evaluation of lipophilicity of 3-arylidenefl avanones 2b, 2c, and 2i
The log P values for the tested compounds were calculated using the Gaussian G09 program package (Frisch et al., 2009) . Structures of the compounds were optimized on the DTF level of theory using the B3LYP (Becke, 1988; Lee et al., 1988) functional and 6-31++G(d,p) (Ditchfi eld et al., 1971; Hehre et al., 1972; Hariharan and Pole, 1973) basis sets. The following calculation of energies of the compounds in water and n-octanol were performed on the same level of theory using the SMD solvation model (Merenich et al., 2009) . The values of the partition coeffi cient of each compound were calculated from the difference of the compound's energy in water and n-octanol using the equation developed by Leo et al. (1971) .
Evaluation of minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of the compounds
The reference Staphylococcus aureus ATCC 29213, S. epidermidis ATCC 12228, Enterococcus faecalis ATCC 29212 strains, nine Staphylococcus spp. clinical strains (from our own collection), and 10 Enterococcus spp. strains (a gift from the collection of Prof. W. Hryniewicz, National Medicinal Institute, Warsaw, Poland) were used as targets for the tested synthetic fl avonoids. Sterile stock solutions of each compound at the concentration of 60.0 mg/ml were prepared in DMSO (dimethyl sulfoxide). The agent concentration range used in the antimicrobial tests was 0.29 -300.0 μg/ml prepared in Mueller-Hinton broth (Difco, Detroit, USA). DMSO alone was always used as a negative control. Prior to the assay, the strains were evaluated for antibiotic susceptibility, using the standard disc diffusion and/or broth microdilution MIC tests, according to CLSI (2006) (M7-A5) .
MIC values were specifi ed as the concentrations of compounds at which microbial growth was inhibited during a 24-h culture; the turbidity was thus equal to A 600 of the culture medium used as a blank control (0.06). The solubilizer DMSO at a concentration of 10 ml/l (the same as the highest fi nal concentration used for the dilution of compounds) had no antimicrobial activity itself.
The lowest concentration of compounds bactericidal to 99.9% of the original inoculum was determined by subculturing 10 μl from the wells of MIC, 2 MIC, and 4 MIC to the broth media without antimicrobial agent. The concentration at which no visible growth after a subsequent 24-h incubation is observed means MBC. The compound is regarded bactericidal if the MBC value is not greater than four times the MIC value. Another 10 μl from the well of MIC, 2 MIC, and 4 MIC were subcultured onto agar media without compounds, for evaluation of CFU (colony-forming units) and colony appearance.
In the reference experiments, the following standard antibiotics were used: ampicillin (Serva, Heidelberg, Germany), ofl oxacin (Sigma, Munich, Germany), penicillin, methicillin, oxacillin, gentamicin, vancomycin, erythromycin, tetracycline, teicoplanin, ciprofl oxacin, chloramphenicol, linezolid, rifampicin, imipenem (Mast Diagnostics, Merseyside, UK). For comparison, four phytochemicals, quercetin (3,3',4',5,7-pentahydroxyfl avone), naringin (4',5,7-trihydroxyfl avanone-7-rhamnoglucoside), naringenin [5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one], and thymol (2-isopropyl-5-methylphenol), purchased from Sigma were used.
Determination of bacterial growth rate in the presence of 3-arylidenefl avanones 2b and 2c
The growth rates of S. aureus ATCC 29213 (reference MSSA-methicillin-sensitive), S. aureus A3 (clinical methicillin-resistant), E. faecalis ATCC 29212 (reference vancomycin-sensitive), and E. faecium 138/09 (clinical vancomycin-resistant), cultured for 4, 8 or 24 h at 37 °C in a 96-well microplate in the presence of 3-arylidenefl avanones 2b or 2c at MIC, were evaluated. The results were compared with the bacterial growth rate in the presence of oxacillin MIC (for staphylococci) or vancomycin MIC (for enterococci). After the incubation, compound/antibiotic concentrations causing 50% or 90% reduction, respectively, in microbial growth at each time point were deter-mined (turbidity at A 600 ) and compared. Experiments were performed in duplicate to confi rm the reproducibility of the results. Results are presented as the mean A 600  S.D.
Enumeration of viability and aggregation of bacterial cells treated with 3-arylidenefl avanone 2c
The potential effect of 3-arylidenefl avanone 2c on bacterial cell membranes was assessed by 2c-mediated uptake of SYTO 9 and propidium iodide (LIVE/DEAD BacLight Bacterial Viability kit, L7007, Molecular Probes, Invitrogen, Eugene, USA). Cell suspensions of S. aureus ATCC 29213 and E. faecalis ATCC 29212 in PBS (1.0 · 10 6 CFU/ml) were incubated with MIC, ½ MIC or ¼ MIC of 2c at 37 °C for 4 h with shaking. After incubation, bacteria were washed with 5 ml sterile PBS, and stained using the LIVE/DEAD kit according to the manufacturer's recommendations. Cells with LIVE/DEAD and no 2c served as negative controls. After the incubation, all samples were washed and resuspended in PBS, and a drop of each suspension was examined with a confocal laser scanning microscope for green/ red fl uorescence using fl uorescein and Texas red band-pass fi lters to visualize SYTO 9 and propidium iodide, respectively. Six areas of each of the triplicate samples were photographed with an integrated Hamamatsu digital camera (C4742-95; Nikon, Tokyo, Japan).
Additionally, in order to test whether the compound induces aggregation of the cells, 25 μl of bacterial suspension treated as described above were placed on a glass microscopic slide and gently smeared. After air-drying, heat-fi xation, and Gram staining, slides were examined by light microscopy for the presence of clusters, in comparison to the control (non-treated bacteria), according to the score established by Cushnie et al. (2007) .
Effects of combinations of 3-arylidenefl avanone 2c and antibiotics on S. aureus and E. faecium cells
Two-fold dilutions of one antibiotic (oxacillin for S. aureus A3 or vancomycin for E. faecium 138/09) in combination with ½ MIC or MIC of 2c were used in the test for potential synergy. The fractional inhibitory concentration (FIC), which is an interaction coeffi cient indicating whether the combined inhibitory effect is synergistic, additive or antagonistic, was calculated for each combination that inhibited growth. The following formula was used: FIC = (MIC of antibiotic in combination with 2c/MIC of antibiotic alone) + (MIC of 2c in combination/MIC of 2c alone). The average FIC index (FICI) was calculated from individual FIC values. FICI ≤ 0.5 was defi ned as synergistic, >0.5 -1 as additive, >1 -<2 as indifferent, and 2 as antagonistic (EUCAST, 2000) .
Bacterial adherence, biofi lm formation, and their suppression under the infl uence of 3-arylidenefl avanone 2c
Bacteria (S. aureus ATCC 29213 and E. faecalis ATCC 29212) were grown for 24 h at 37 °C in 5 ml of tryptic-soy broth (TSB) supplemented with 0.25% D-(+)-glucose (TSBGlc). The cultures were diluted 1:40 in TSBGlc and 200 μl were added to the wells of a 96-well tissue culturetreated polystyrene plate (Nunclon™ Surface No. 167008; Nunc, Roskilde, Denmark). The adherence and biofi lm formation in the absence or presence of 2c (at ½ MIC and MIC) were evaluated after 2 h or 24 h of incubation, respectively, at 37 °C. The infl uence of 3-arylidenefl avanone 2c (at a concentration equal to MIC, 2 -8 MIC) on preformed biofi lms was determined. For this, 2c was added to 24-h-old biofi lms for further 24 -48 h of incubation at 37 °C (total biofi lm age was 72 h). After the above-mentioned treatments, adherent bacterial cells/biofi lm mass was stained with MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Sigma, St. Louis, USA] as described earlier (Walencka et al., 2005 (Walencka et al., , 2007 . In this assay, live bacteria with an active electron transport system reduce the tetrazolium salt to a water-soluble purple formazan product, and optical density values are directly dependent on their cell numbers. Results are presented as the mean A 550  S.D.
Results
Twenty two synthetic fl avonoids, i.e. 2'-hydroxychalcones, 3-arylidenefl avanones, and 3-arylidenechromanones (structures shown in Table I ), were screened for their in vitro minimal inhibitory concentration (MIC) against an important group of "alert" human pathogens -Staphylococcus and Enterococcus spp. The concentration range of each compound was 0.29 -300.0 μg/ml (eleven two-fold dilutions). The 2'-hydroxychalcones 1a, 1b, and 1c showed an unsatisfactory effect (MIC 150 -300 μg/ml; 624.4 -1248.8 μM) against reference strains. On the other hand, three out of nine members of the 3-arylidenefl avanones group (2b, 2c, and 2i) showed potent activity, with MIC values ranging from 4.68 μg/ml (14.3 μM) to 37.5 μg/ ml (119.7 μM) (Tables II, III) .
The main goal of the next part of the study was to see whether 2b
[(E)-3-(4-hydroxybenzylidene)-2,3-dihydro-2-phe nyl chroman-4-one] and 2i [(E)-3-(3-hydroxybenzylidene)-2,3-dihydro-2-phenylchroman-4-one] are equally potent against antibiotic-susceptible and multidrug-resistant strains. For this experiment, we selected a range of clinical isolates from blood, cerebrospinal fl uid, catheter swab, and stool of hospitalized patients with local or systemic infections. Strong activity of these compounds was indeed observed, regardless of the antibiotic susceptibility profi les of the strains. Active concentrations ranged from 4.68 μg/ml to 75.0 μg/ml (Tables II, III) . MIC values of these compounds were much lower than those of the natural fl avonoids quercetin (>300.0 μg/ml) and naringenin (300.0 μg/ml), and lower or equal to the MIC of thymol, a compound with known antibacterial activity (18.75 μg/ml for S. aureus; 75.0 μg/ml for E. faecalis) and lower than MIC values of the reference antibiotics. In Tables II and III , MIC values of compound 2b and 2c are presented in both micrograms per ml and in micromolar concentration, however, later in the text micrograms per ml were used, as for the reference antibiotics. Compound 2i, differing from 2c only in the OH substituent at the phenyl ring and showing similar MIC values, was not included in the further study.
The experiment designed to test the kinetics of the compounds' action showed that the 3-arylidenefl avanones 2b and 2c at MIC (18.75 and 4.68 μg/ml, respectively) effi ciently reduced the number of staphylococci by approximately 50% within 4 h and by 90% within 8 h. The time-dependent effect was comparable to the action of the standard β-lactam antibiotic, oxacillin, used against MSSA at a concentration of 0.5 μg/ml (Fig. 1A) . Compounds 2b and 2c used at these relatively low MIC values, also effi ciently reduced the multiplication of MRSA, while as much as 128.0 μg/ml of oxacillin was needed to obtain the same effect (Fig. 1B) . Similar time-dependent antibacterial activity of these compounds was found when E. faecalis and E. faecium were used as target microorganisms and confronted with the action of the reference antibiotic vancomycin. This antibiotic was used for sensitive and resistant strains at a concentration of 2 μg/ml or 64.0 μg/ ml, respectively (Figs. 2A, B) . The answer to the question of whether 2b and 2c are bacteriostatic or bactericidal was provided by two parallel tests. A CFU counting test revealed 99.9% reduction of the original inoculum by 2 -4 MIC of 2b and 2c which indicated their bactericidal effect. However, subculturing of the same samples on broth media showed bacterial regrowth. This observation would rather indicate that 2b and 2c are not bactericidal but bacteriostatic. This interpretation was supported by the appearance and characteristics of the colonies recovered on the solid medium. They were differentiated (small and large) which refl ects the infl uence of 2b and 2c on the cell wall and/or on the cell membrane integrity. This was also proved by experiments for 2c-mediated SYTO 9/propidium iodide uptake, evaluated by fl uorescent confocal microscopy. As assessed by the emission of green/ red fl uorescence, non-treated staphylococcal as well as enterococcal cells showed only green fl uorescence (live with undamaged cell wall), except for very few red cells. However, 2c-treated cells (¼ MIC, ½ MIC, MIC) exhibited increased uptake of propidium iodide (leaking cell wall and membrane), proportional to the increase in its concentration. When samples were examined by light microscopy, the majority of bacteria treated with 2c were found in small and large aggregates, as compared to pairs and small clusters in control samples. Also, the size and shape of the cells was changed under the infl uence of the compounds applied (data not shown). Our observations indicate that this effect is reversible, since bacteria from colonies of different sizes subcultured onto medium without antimicrobial chemicals had the correct parental morphology.
The synergistic activity against the S. aureus A3 clinical strain was observed for combinations of 2c used at MIC and oxacillin (FICI = 0.01). 2c used at ½ MIC also increased signifi cantly (64-fold) the oxacillin susceptibility of S. aureus, however, the FICI value was on the border between synergy and additive effect (FICI = 0.58). The similar observation was made concerning vancomycin susceptibility changes of the E. faecium 138/09 clinical strain in the presence of 2c. Synergy of vancomycin and 2c used at MIC was observed (FICI = 0.003), whereas an antibiotic in combination with ½ MIC of 2c showed an additive effect, reducing the value of the vancomycin MIC to 1 ⁄8 (FICI = 0.97) ( Table IV) . The effect of 2c on adhesion to and formation of a biofi lm by S. aureus ATCC 29213 and E. faecalis ATCC 29212 strains on a polystyrene surface was evaluated. After MTT staining, the mean A 550 value for S. aureus after 2 h was 0.55  0.02, and after 24 h it was 2.96  0.01. The mean A 550 value for E. faecalis after 2 h was 0.40  0.12, and after 24 h it was 1.68  0.06. Therefore these strains were recognized as a strong biofi lm producer. The inhibition of their initial adhesion ranged from 47.8% (½ MIC) to 54.5% (MIC) and from 42.9% (½ MIC) to 54.5% (MIC), respectively, for S. aureus and E. faecalis.
Such a strong inhibitory effect of 2c resulted in a decrease in E. faecalis biofi lm formation by 27.9% (mean A 550 1.21  0.06 at ½ MIC) and by 49.4% (mean A 550 0.83  0.06 at MIC). Unfortu- nately, although the early adhesion of staphylococci in the presence of 2c (½ MIC) was reduced by nearly 50%, it did not stop biofi lm formation during a 24-h co-incubation. However, when 2c was used for this purpose at MIC, the S. aureus biofi lm formation was inhibited by 50% (mean A 550 dropped from 2.96  0.01 to 1.47  0.12). On the other hand, 2b and 2c used at MIC as well as at 4 -8 MIC, failed to cause complete eradication of the S. aureus and E. faecalis biofi lms which had been already preformed. The degree of biomass reduction obtained was not significant (5 -10%).
Discussion
Our study has revealed the potent antibacterial activity of some synthetic 3-arylidenefl avanones. Similarly to our results, fl avanones were often shown to be most active against Gram (+ve) bacteria (Cushnie and Lamb, 2005; Alcaraz et al., 2000; Nishino et al., 1987; Jeong et al., 2009) . For example, remagifl avanone A and B, isolated from the methanolic extract of dried leaves of Physena madagascariensis demonstrated activity against S. aureus at 3.75 μg/ml and against E. faecalis at 7.5 μg/ml, whereas against various Gram (-ve) bacteria the active concentration was as high as 125.0 μg/ml (Deng et al., 2000) . Thus, our results concerning the antibacterial activity of compounds 2c and 2i are satisfactory. Other authors, who tested twelve commercially available natural fl avanones, identifi ed six of them as good candidates to be antimicrobials despite their MIC values ranging from 128.0 to 512.0 μg/ml (Jeong et al., 2009 ). According to many authors, natural, semi-synthetic or synthetic compounds capable of inhibiting bacterial growth at a concentration lower than 10 μg/ml are worth further study (Gibbons, 2008; Cushnie and Lamb, 2005) . Such requirements were met by our three compounds (2b, 2c, and 2i) showing MIC values ranging from 4.68 μg/ml to 37.5 μg/ml; however, these were not bactericidal.
Among Gram (+ve) bacteria, increasing concerns have been voiced about nosocomial and community-associated staphylococci (MRSA), and vancomycin-resistant enterococci (VRE) (Rice, 2006) . However, biofi lm formation by these bacteria is a major medical problem and the most important one to be resolved (Goetz, 2002; Mohamed and Huang, 2007) . Due to the high resistance of biofi lms to antibiotics and host-derived immune factors, the ideal solution to avoid their engagement in the pathogenesis process would be to prevent their development (Hoiby et al., 2010; Dürig et al., 2010) .
Thus, one of the main questions we posed was whether these compounds may be considered effective agents in anti-biofi lm therapy. Indeed, we have demonstrated that these compounds were effective against staphylococcal and entrococcal adhesion and biofi lm formation. Unfortunately, the reduction in biomass and disruption of mature biofi lm structure by our synthetic fl avonoids was not signifi cant. There is general agreement that complete eradication of biofi lm-embedded bacteria by medical therapy is hard to achieve, but it is possible that their pretreatment with natural phytochemicals or synthetic analogues, though not suffi cient for eradication, could increase the antibiotic effect by disruption of the bio fi lm integrity. So, our fi ndings suggest that 3-arylidenefl avanones, and in particular compound 2c, alone or in combination with antibiotics, might be useful in controlling MRSA and VRE infections. Compound 2c, used even in the sub-inhibitory concentration, reduced MRSA resistance to the β-lactam antibiotic (oxacillin) and VRE resistance to the glycopeptide antibiotic (vancomycin). In view of the rising prevalence of multi-resistant staphylococci and enterococci, such a combined therapy may be useful in improving the effi cacy of "old" antibiotics.
When comparing the chemical structures of more and less biologically active compounds, two features seem to be characteristic. For high activity the fi rst one is the presence of the phenyl group of the most powerful 3-arylidenefl avanones 2b and 2c. The 3-arylidenechromanones 3b and 3c, which are closely related to them (albeit-inactive), do not have this substituent. The second one is the importance of the 3-or 4-hydroxyphenyl group, respectively, at R 3 of 2c and 2i. In this case, the two compounds are equally effi cient. The related compound 2a with an unsubstituted phenyl ring at this site was inactive. The requirement of at least one hydroxyphenyl group and a certain degree of lipophilicity for fl avonoids to display antimicrobial activity was reported earlier (Cushnie and Lamb, 2005; Mughal et al., 2006; Avila et al., 2008) . It should also be noted that other sub- stituents in the 3-arylidenefl avanone phenyl ring such as halogen atoms (F, Cl, Br) in 2e -2g and the -CN group in 2h do not increase the antimicrobial effi cacy of these derivatives. For certain natural or modifi ed fl avonoids, the mechanisms underlying their antimicrobial action are already known (Gibbons, 2008; Cushnie and Lamb, 2005) . It is suggested, however, that an individual compound may have multiple cellular targets, rather than one specifi c site of action. Although it is diffi cult to predict the pharmacodynamic features of such agents, their good penetration, direct membrane damage, and lipophilicity seem to be the most important properties of potential drugs. It is also possible that they affect the hydrophobicity of the bacterial cell surface. By decreasing the expression of surface-exposed hydrophobins, these chemicals could interfere with the adhesion step essential in biofi lm development. Such an effect observed in our study could be the result of the relatively high lipophilicity of synthetic fl avanones (partition coeffi cient log P for 2b = 1.54, for 2c = 2.13, for 2i = 2.30, calculated by mathematical analysis). It suggests that synthetic compounds tested in the present work may easily penetrate biological membranes, probably without any help of active transport mechanisms, thus being promising as future alternative therapeutic agents.
